These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 6803566

  • 1. Captopril in the long-term treatment of essential hypertension: changes in the renin-angiotensin-aldosterone system.
    Riegger GA, Steilner H, Hayduk K, Liebau G.
    Am J Cardiol; 1982 Apr 21; 49(6):1555-7. PubMed ID: 6803566
    [Abstract] [Full Text] [Related]

  • 2. Captopril treatment: inter-dose variations in renin, angiotensins I and II, aldosterone and blood pressure.
    Atkinson AB, Cumming AM, Brown JJ, Fraser R, Leckie B, Lever AF, Morton JJ, Robertson JI.
    Br J Clin Pharmacol; 1982 Jun 21; 13(6):855-8. PubMed ID: 7046776
    [Abstract] [Full Text] [Related]

  • 3. Captopril in clinical hypertension. Changes in components of renin-angiotensin system and in body composition in relation to fall in blood pressure with a note on measurement of angiotensin II during converting enzyme inhibition.
    Atkinson AB, Morton JJ, Brown JJ, Davies DL, Fraser R, Kelly P, Leckie B, Lever AF, Robertson JI.
    Br Heart J; 1980 Sep 21; 44(3):290-6. PubMed ID: 7000102
    [Abstract] [Full Text] [Related]

  • 4. Effect of captopril on the renin-angiotensin system in hypertensive children.
    Friedman AL, Chesney RW.
    J Pediatr; 1983 Nov 21; 103(5):806-10. PubMed ID: 6355422
    [Abstract] [Full Text] [Related]

  • 5. Hormonal changes with long-term converting-enzyme inhibition by captopril in essential hypertension.
    Matthews PG, McGrath BP, Johnston CI.
    Clin Sci (Lond); 1979 Dec 21; 57 Suppl 5():135s-138s. PubMed ID: 232017
    [Abstract] [Full Text] [Related]

  • 6. [An experimental study on the effects of the chronic administration of an angiotensin converting enzyme inhibitor (captopril) on blood pressure and the renin-angiotensin-aldosterone system (author's transl)].
    Goto A.
    Nihon Naibunpi Gakkai Zasshi; 1980 Jun 20; 56(6):868-83. PubMed ID: 6997093
    [Abstract] [Full Text] [Related]

  • 7. Captopril in hypertension with renal artery stenosis and in intractable hypertension; acute and chronic changes in circulating concentrations of renin, angiotensins I and II and aldosterone, and in body composition.
    Atkinson AB, Brown JJ, Fraser R, Leckie B, Lever AF, Morton JJ, Robertson JI.
    Clin Sci (Lond); 1979 Dec 20; 57 Suppl 5():139s-143s. PubMed ID: 396067
    [No Abstract] [Full Text] [Related]

  • 8. Effects of angiotensin I converting enzyme inhibitor (SQ 14,225) on the responses of blood pressure and steroid hormone to angiotensin II and ACTH infusion in hypertensive subjects.
    Ueda Y, Honda M, Hatano M.
    Jpn Circ J; 1982 Mar 20; 46(3):267-73. PubMed ID: 6278173
    [Abstract] [Full Text] [Related]

  • 9. Rise in plasma concentration of aldosterone during long-term angiotensin II suppression.
    Staessen J, Lijnen P, Fagard R, Verschueren LJ, Amery A.
    J Endocrinol; 1981 Dec 20; 91(3):457-65. PubMed ID: 7035596
    [Abstract] [Full Text] [Related]

  • 10. The renin-angiotensin system during converting enzyme inhibition with captopril in patients with severe treatment-resistant hypertension.
    Rasmussen S, Damkjaer Nielsen M, Ibsen H, Leth A, Giese J.
    Eur J Clin Invest; 1984 Feb 20; 14(1):30-6. PubMed ID: 6321195
    [Abstract] [Full Text] [Related]

  • 11. Effect of infused captopril on blood pressure and the renin-angiotensin-aldosterone system in normal dogs subjected to varying sodium balance.
    Morton JJ, Tree M, Casals-Stenzel J.
    Am J Cardiol; 1982 Apr 21; 49(6):1395-400. PubMed ID: 7041583
    [Abstract] [Full Text] [Related]

  • 12. [Effect of inhibition of converting enzyme by captopril on arterial pressure, renin and aldosterone in essential hypertension].
    Posadas C, Sánchez G, Boyer JL, Delmar M, Serrano PA.
    Arch Inst Cardiol Mex; 1982 Apr 21; 52(4):295-300. PubMed ID: 6291470
    [Abstract] [Full Text] [Related]

  • 13. Primacy of the renin-angiotensin system in mediating the aldosterone response to sodium restriction.
    Swartz SL, Williams GH, Hollenberg NK, Dluhy RG, Moore TJ.
    J Clin Endocrinol Metab; 1980 Jun 21; 50(6):1071-4. PubMed ID: 6989849
    [Abstract] [Full Text] [Related]

  • 14. [A new principle in long-term treatment of essential hypertension: angiotensin-converting enzyme inhibition (author's transl)].
    Overlack A, Stumpe KO, Heck I, Krück F.
    Dtsch Med Wochenschr; 1980 Apr 11; 105(15):505-9. PubMed ID: 6244920
    [Abstract] [Full Text] [Related]

  • 15. Hormonal and metabolic effects of angiotensin converting enzyme inhibitors. Possible differences between enalapril and captopril.
    Atlas SA, Case DB, Yu ZY, Laragh JH.
    Am J Med; 1984 Aug 20; 77(2A):13-7. PubMed ID: 6089554
    [Abstract] [Full Text] [Related]

  • 16. Participation of the renin system in treatment-resistant hypertension as measured by acute blockade of the angiotensin converting enzyme.
    Weber MA, Drayer JI, Priest RT, Chen TC.
    Am J Nephrol; 1982 Aug 20; 2(1):6-11. PubMed ID: 6295161
    [Abstract] [Full Text] [Related]

  • 17. Captopril in primary hypertension. Effects related to the renin-angiotensin-aldosterone and kallikrein-kinin systems.
    Ohman KP, Karlberg BE, Nilsson OR, Wettre S.
    Acta Med Scand Suppl; 1981 Aug 20; 646():98-105. PubMed ID: 7018190
    [Abstract] [Full Text] [Related]

  • 18. Long-term effects of captopril (SQ14 225) on blood-pressure and hormone levels in essential hypertension.
    Johnston CI, Millar JA, McGrath BP, Matthews PG.
    Lancet; 1979 Sep 08; 2(8141):493-6. PubMed ID: 90216
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.